+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Precision Diagnostics & Medicine Market - Global Forecast 2026-2032- Product Image
Precision Diagnostics & Medicine Market - Global Forecast 2026-2032- Product Image
Sale

Precision Diagnostics & Medicine Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6055133
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Precision Diagnostics & Medicine Market is projected to reach USD 171.73 Billion in 2026. It is expected to continue growing at a CAGR of 11.41%, reaching USD 330.62 Billion by 2032.

Precision Diagnostics and Medicine: Executive Summary

Precision diagnostics and medicine align prevention, diagnosis, treatment selection, and monitoring with individual biological and clinical characteristics. The field combines molecular testing, imaging, digital health data, clinical evidence, and data-enabled decision support. Its central value proposition is more informed care: identifying disease earlier, matching interventions more appropriately, and reducing avoidable treatment exposure while maintaining clinical oversight.

From Broad Protocols to Data-Guided Care Pathways

The landscape is shifting from predominantly population-level protocols toward stratified care pathways based on biomarkers, genomic findings, longitudinal records, and patient characteristics. This transition is supported by advances in sequencing, liquid biopsy, imaging, companion diagnostics, and interoperable health information systems. Adoption remains dependent on analytical validity, clinical utility, reimbursement, laboratory quality, clinician training, privacy safeguards, and equitable access. Evidence standards and regulatory expectations are therefore becoming as important as technical capability.

Artificial Intelligence Strengthens Interpretation and Workflow

Artificial intelligence is expanding the analytical capacity of precision diagnostics by supporting image interpretation, signal detection, risk stratification, variant prioritization, workflow triage, and integration of complex datasets. Its practical impact depends on representative training data, transparent validation, cybersecurity, human review, and monitoring for performance drift and bias. AI should augment laboratory and clinical expertise rather than replace accountability, particularly when outputs influence diagnosis, treatment selection, or urgent care decisions.

Regional Insights: Uneven Infrastructure, Shared Priorities

North America combines advanced research, laboratory, and digital-health capabilities with complex reimbursement and data-governance requirements. Europe emphasizes evidence, privacy, cross-border data coordination, and health-system integration. Asia-Pacific presents strong innovation capacity alongside substantial variation in infrastructure, access, and regulatory maturity. Latin America is prioritizing diagnostic availability, regional collaboration, and affordability. The Middle East is investing in modern healthcare infrastructure and genomics, while implementation varies across systems. Africa has significant unmet diagnostic needs and growing innovation potential, with workforce capacity, financing, connectivity, and supply-chain resilience remaining central priorities.

Group Insights: Cooperation Shapes Adoption Conditions

ASEAN cooperation can support shared standards, laboratory networks, workforce development, and more efficient access across diverse health systems. BRICS members offer broad scientific, manufacturing, and healthcare perspectives, while differences in regulation and infrastructure require adaptable implementation models. The European Union benefits from coordinated policy, research collaboration, and data-governance frameworks, although national health-system differences remain material. G7 countries contribute substantial research and regulatory capacity. GCC states are strengthening integrated, technology-enabled healthcare systems, and NATO members increasingly recognize diagnostics resilience, cybersecurity, and continuity of medical supply as strategic concerns.

Country Insights: Distinct Capabilities and Implementation Priorities

Australia emphasizes national coordination, genomics, and equitable access across geographically dispersed populations. Brazil is balancing research capability with public-system scale and regional access challenges. Canada is advancing precision health through research networks while addressing provincial variation and Indigenous health equity. China is expanding genomics, digital infrastructure, and domestic capabilities within an evolving regulatory environment. France, Germany, Italy, and Spain are integrating precision approaches into established European health systems, with attention to evidence, reimbursement, data protection, and laboratory standards. India is combining strong technical talent with major affordability and access requirements. Japan and South Korea pair advanced healthcare technology with aging-population needs and rigorous quality expectations. Mexico is focused on strengthening diagnostic capacity and reducing geographic disparities. Russia’s priorities include domestic capability, access, and system resilience. The United Kingdom and United States remain influential in research, clinical translation, regulation, and data-enabled care, while facing cost, interoperability, privacy, and equity challenges.

Actions for Leaders: Build Evidence, Trust, and Access

Industry leaders should prioritize clinically meaningful use cases with clear decision pathways and measurable patient outcomes. They should establish end-to-end quality systems covering specimen handling, assay validation, algorithm performance, cybersecurity, and post-deployment monitoring. Partnerships with laboratories, providers, payers, researchers, and patient groups can improve evidence generation and adoption. Interoperability should be designed into products from the outset, alongside transparent consent and data-governance practices. Leaders should also develop tiered deployment models, workforce training, and access strategies that address differences in infrastructure and affordability rather than concentrating benefits in well-resourced settings.

Research Methodology: Evidence-Led Market Assessment

This executive summary uses a structured review of the precision diagnostics and medicine landscape, emphasizing publicly verifiable information from regulatory materials, peer-reviewed research, clinical guidance, health-system documentation, standards, and authoritative policy sources. Findings were synthesized thematically across technology, clinical adoption, artificial intelligence, infrastructure, regulation, workforce, access, and data governance. Regional, group, and country comparisons were framed qualitatively to avoid unsupported numerical claims. The assessment distinguishes established applications from emerging practices and treats implementation context as a core determinant of real-world value.

Conclusion: Precision Care Requires Integrated Execution

Precision diagnostics and medicine are moving toward more individualized, continuously informed care, but technical progress alone will not determine outcomes. Sustainable adoption requires validated tests, dependable data, clinically useful interpretation, responsible AI, interoperable systems, appropriate payment, skilled professionals, and safeguards for privacy and equity. Organizations that connect innovation with evidence, operational readiness, and patient trust will be better positioned to translate precision capabilities into consistent improvements in care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Precision Diagnostics & Medicine Market, by Product
7.1. Introduction
7.2. Antiviral Drugs
7.3. Cell & Gene Therapies
7.4. Inhibitor Drugs
7.5. Monoclonal Antibodies
8. Precision Diagnostics & Medicine Market, by Technology
8.1. Introduction
8.2. Genomics
8.3. Molecular Diagnostics
8.3.1. Next-Generation Sequencing
8.3.2. Polymerase Chain Reaction
8.4. Proteomics
9. Precision Diagnostics & Medicine Market, by Application
9.1. Introduction
9.2. Disease Diagnosis
9.2.1. Chronic Diseases
9.2.2. Genetic Disorders
9.3. Precision Therapeutics
9.3.1. Personalized Medicine
9.3.2. Targeted Therapies
9.4. Research & Development
10. Precision Diagnostics & Medicine Market, by End User
10.1. Introduction
10.2. Clinical Laboratories
10.2.1. Diagnostic Laboratories
10.2.2. Research Laboratories
10.3. Hospitals
11. Precision Diagnostics & Medicine Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Precision Diagnostics & Medicine Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Precision Diagnostics & Medicine Market, by Country
13.1. Introduction
13.2. United States
13.3. Germany
13.4. China
13.5. United Kingdom
13.6. India
13.7. Japan
13.8. Russia
13.9. Brazil
13.10. Canada
13.11. Italy
13.12. Mexico
13.13. France
13.14. Spain
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. AstraZeneca PLC
15.3. Baxter International Inc.
15.4. Becton, Dickinson and Company
15.5. Biogen Inc.
15.6. Bristol-Myers Squibb Company
15.7. Danaher Corporation
15.8. F. Hoffmann-La Roche Ltd
15.9. GE Healthcare Technologies, Inc.
15.10. Illumina, Inc.
15.11. International Business Machines Corp.
15.12. Johnson & Johnson Services, Inc.
15.13. Koninklijke Philips N.V.
15.14. Lantheus Medical Imaging, Inc.
15.15. Medtronic PLC
15.16. Myriad Genetics Inc.
15.17. Novartis AG
15.18. OneOme, LLC
15.19. Pfizer Inc.
15.20. Qiagen NV
15.21. Quest Diagnostics Incorporated
15.22. Sanofi S.A.
15.23. Siemens Healthineers
15.24. Swiss Precision Diagnostics GmbH
15.25. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Precision Diagnostics & Medicine Market, Years Considered for the Study
FIGURE 2. Global Precision Diagnostics & Medicine Market, Research Design
FIGURE 3. Global Precision Diagnostics & Medicine Market, Research Framework
FIGURE 4. Global Precision Diagnostics & Medicine Market, Data Triangulation
FIGURE 5. Global Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Precision Diagnostics & Medicine Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Precision Diagnostics & Medicine Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Precision Diagnostics & Medicine Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Precision Diagnostics & Medicine Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Precision Diagnostics & Medicine Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Precision Diagnostics & Medicine Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Precision Diagnostics & Medicine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Precision Diagnostics & Medicine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Precision Diagnostics & Medicine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Precision Diagnostics & Medicine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Precision Diagnostics & Medicine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Precision Diagnostics & Medicine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Precision Diagnostics & Medicine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Precision Diagnostics & Medicine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Precision Diagnostics & Medicine Market Segmentation & Coverage
TABLE 2. Global Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Antiviral Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Antiviral Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Antiviral Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Cell & Gene Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Cell & Gene Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Cell & Gene Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Inhibitor Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Inhibitor Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Inhibitor Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 17. Global Genomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Genomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Genomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Molecular Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Next-Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Next-Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Next-Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Proteomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Proteomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Proteomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 33. Global Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Disease Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Chronic Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Chronic Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Chronic Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Genetic Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Genetic Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Genetic Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Precision Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Precision Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Precision Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Personalized Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Personalized Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Personalized Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Targeted Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Targeted Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Targeted Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Research & Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Research & Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Research & Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 55. Global Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Research Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Research Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Research Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Precision Diagnostics & Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Precision Diagnostics & Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 77. North America Precision Diagnostics & Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. North America Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 79. North America Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 80. North America Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 81. North America Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. North America Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 83. North America Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 84. North America Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. North America Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 86. Latin America Precision Diagnostics & Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Latin America Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 88. Latin America Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 89. Latin America Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 90. Latin America Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. Latin America Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 92. Latin America Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 93. Latin America Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Latin America Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 95. Europe Precision Diagnostics & Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Europe Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 97. Europe Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 98. Europe Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 99. Europe Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. Europe Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 101. Europe Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 102. Europe Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Europe Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 104. Middle East Precision Diagnostics & Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Middle East Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 106. Middle East Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 107. Middle East Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 108. Middle East Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. Middle East Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 110. Middle East Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 111. Middle East Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Middle East Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 113. Africa Precision Diagnostics & Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Africa Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 115. Africa Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 116. Africa Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 117. Africa Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. Africa Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 119. Africa Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 120. Africa Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. Africa Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 122. Global Precision Diagnostics & Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. ASEAN Precision Diagnostics & Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. ASEAN Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 125. ASEAN Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 126. ASEAN Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 127. ASEAN Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. ASEAN Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 129. ASEAN Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 130. ASEAN Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. ASEAN Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 132. GCC Precision Diagnostics & Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. GCC Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 134. GCC Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 135. GCC Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 136. GCC Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. GCC Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 138. GCC Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 139. GCC Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. GCC Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 141. European Union Precision Diagnostics & Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. European Union Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 143. European Union Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 144. European Union Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 145. European Union Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. European Union Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 147. European Union Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 148. European Union Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. European Union Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 150. BRICS Precision Diagnostics & Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. BRICS Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 152. BRICS Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 153. BRICS Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 154. BRICS Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. BRICS Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 156. BRICS Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 157. BRICS Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. BRICS Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 159. G7 Precision Diagnostics & Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. G7 Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 161. G7 Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 162. G7 Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 163. G7 Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 164. G7 Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 165. G7 Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 166. G7 Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. G7 Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 168. NATO Precision Diagnostics & Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. NATO Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 170. NATO Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 171. NATO Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 172. NATO Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. NATO Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 174. NATO Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 175. NATO Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. NATO Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 177. Global Precision Diagnostics & Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 178. United States Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 179. United States Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 180. United States Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 181. United States Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 182. United States Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. United States Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 184. United States Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 185. United States Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. United States Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 187. Germany Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 188. Germany Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 189. Germany Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 190. Germany Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 191. Germany Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Germany Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 193. Germany Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 194. Germany Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Germany Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 196. China Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 197. China Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 198. China Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 199. China Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 200. China Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. China Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 202. China Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 203. China Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. China Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 205. United Kingdom Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 206. United Kingdom Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 207. United Kingdom Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. United Kingdom Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 209. United Kingdom Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. United Kingdom Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 211. United Kingdom Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 212. United Kingdom Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. United Kingdom Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 214. India Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 215. India Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 216. India Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 217. India Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 218. India Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. India Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 220. India Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 221. India Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. India Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 223. Japan Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 224. Japan Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 225. Japan Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 226. Japan Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 227. Japan Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. Japan Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 229. Japan Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 230. Japan Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Japan Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 232. Russia Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 233. Russia Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 234. Russia Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 235. Russia Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 236. Russia Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 237. Russia Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 238. Russia Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 239. Russia Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. Russia Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 241. Brazil Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 242. Brazil Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 243. Brazil Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 244. Brazil Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 245. Brazil Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. Brazil Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 247. Brazil Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 248. Brazil Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Brazil Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 250. Canada Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 251. Canada Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 252. Canada Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 253. Canada Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 254. Canada Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. Canada Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 256. Canada Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 257. Canada Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. Canada Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 259. Italy Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 260. Italy Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 261. Italy Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 262. Italy Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 263. Italy Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 264. Italy Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 265. Italy Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 266. Italy Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Italy Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 268. Mexico Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 269. Mexico Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 270. Mexico Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 271. Mexico Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 272. Mexico Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. Mexico Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 274. Mexico Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 275. Mexico Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. Mexico Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 277. France Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 278. France Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 279. France Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 280. France Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 281. France Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. France Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 283. France Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 284. France Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. France Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 286. Spain Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 287. Spain Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 288. Spain Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 289. Spain Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 290. Spain Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 291. Spain Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 292. Spain Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 293. Spain Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. Spain Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 295. Australia Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 296. Australia Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 297. Australia Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 298. Australia Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 299. Australia Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. Australia Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 301. Australia Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 302. Australia Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. Australia Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 304. South Korea Precision Diagnostics & Medicine Market Size, 2017-2032 (USD Million)
TABLE 305. South Korea Precision Diagnostics & Medicine Market Size, by Product, 2017-2032 (USD Million)
TABLE 306. South Korea Precision Diagnostics & Medicine Market Size, by Technology, 2017-2032 (USD Million)
TABLE 307. South Korea Precision Diagnostics & Medicine Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 308. South Korea Precision Diagnostics & Medicine Market Size, by Application, 2017-2032 (USD Million)
TABLE 309. South Korea Precision Diagnostics & Medicine Market Size, by Disease Diagnosis, 2017-2032 (USD Million)
TABLE 310. South Korea Precision Diagnostics & Medicine Market Size, by Precision Therapeutics, 2017-2032 (USD Million)
TABLE 311. South Korea Precision Diagnostics & Medicine Market Size, by End User, 2017-2032 (USD Million)
TABLE 312. South Korea Precision Diagnostics & Medicine Market Size, by Clinical Laboratories, 2017-2032 (USD Million)
TABLE 313. Global Precision Diagnostics & Medicine Market Share, by Key Player, 2025
TABLE 314. Global Precision Diagnostics & Medicine Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca PLC
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare Technologies, Inc.
  • Illumina, Inc.
  • International Business Machines Corp.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Lantheus Medical Imaging, Inc.
  • Medtronic PLC
  • Myriad Genetics Inc.
  • Novartis AG
  • OneOme, LLC
  • Pfizer Inc.
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • Sanofi S.A.
  • Siemens Healthineers
  • Swiss Precision Diagnostics GmbH
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Precision Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Precision Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 186 Pages
  • Global
From
Precision Diagnostics and Medicine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Precision Diagnostics and Medicine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 146 Pages
  • Global
From
Precision Diagnostics Market Report 2026 - Product Image

Precision Diagnostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Precision Diagnostics and Medicine Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology, Application, End User, Product & Services - Product Image

Precision Diagnostics and Medicine Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology, Application, End User, Product & Services

  • Report
  • 160 Pages
  • Global
From
Precision Diagnostics Market - Global Strategic Business Report - Product Image

Precision Diagnostics Market - Global Strategic Business Report

  • Report
  • 382 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.